AAA
Affinity Asset Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2M | Hold |
80,000
| – | – | 3.31% | 10 |
|
|
2025
Q1 | $26.5M | Sell |
80,000
-2,500
| -3% | -$828K | 2.53% | 7 |
|
|
2024
Q4 | $25.5M | Sell |
82,500
-17,500
| -18% | -$5.4M | 3.41% | 7 |
|
|
2024
Q3 | $21.2M | Sell |
100,000
-10,000
| -9% | -$2.12M | 2.9% | 7 |
|
|
2024
Q2 | $30.8M | Sell |
110,000
-5,000
| -4% | -$1.4M | 3.55% | 3 |
|
|
2024
Q1 | $30.7M | Buy |
115,000
+15,000
| +15% | +$4.01M | 3.8% | 3 |
|
|
2023
Q4 | $23.1M | Buy |
100,000
+15,000
| +18% | +$3.47M | 4.23% | 4 |
|
|
2023
Q3 | $12.4M | Sell |
85,000
-7,500
| -8% | -$1.1M | 3.49% | 8 |
|
|
2023
Q2 | $21.4M | Sell |
92,500
-500
| -0.5% | -$116K | 7.46% | 1 |
|
|
2023
Q1 | $22.5M | Buy |
93,000
+23,000
| +33% | +$5.57M | 7.44% | 2 |
|
|
2022
Q4 | $20.3M | Sell |
70,000
-30,000
| -30% | -$8.71M | 7.97% | 2 |
|
|
2022
Q3 | $6.5M | Hold |
100,000
| – | – | 1.81% | 12 |
|
|
2022
Q2 | $7.16M | Buy |
100,000
+25,000
| +33% | +$1.79M | 3.02% | 9 |
|
|
2022
Q1 | $7.36M | Buy |
75,000
+10,000
| +15% | +$981K | 1.18% | 12 |
|
|
2021
Q4 | $5.51M | Buy |
+65,000
| New | +$5.51M | 2% | 18 |
|
|
2021
Q1 | – | Sell |
-5,000
| Closed | -$556K | – | 69 |
|
|
2020
Q4 | $556K | Buy |
+5,000
| New | +$556K | 0.29% | 52 |
|